McFarland HF - Search Results

1

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

Wandinger KP, Stürzebecher CS, Bielekova B, Detore G, Rosenwald A, Staudt LM, McFarland HF, Martin R. Wandinger KP, et al. Among authors: mcfarland hf. Ann Neurol. 2001 Sep;50(3):349-57. doi: 10.1002/ana.1096. Ann Neurol. 2001. PMID: 11558791

2

Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes.

Pette M, Pette DF, Muraro PA, Farnon E, Martin R, McFarland HF. Pette M, et al. Among authors: mcfarland hf. Neurology. 1997 Aug;49(2):385-92. doi: 10.1212/wnl.49.2.385. Neurology. 1997. PMID: 9270566

3

Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.

Gran B, Hemmer B, Vergelli M, McFarland HF, Martin R. Gran B, et al. Among authors: mcfarland hf. Ann Neurol. 1999 May;45(5):559-67. doi: 10.1002/1531-8249(199905)45:5<559::aid-ana3>3.0.co;2-q. Ann Neurol. 1999. PMID: 10319877 Free PMC article. Review.

4

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.

Muraro PA, Leist T, Bielekova B, McFarland HF. Muraro PA, et al. Among authors: mcfarland hf. J Neuroimmunol. 2000 Nov 1;111(1-2):186-94. doi: 10.1016/s0165-5728(00)00362-3. J Neuroimmunol. 2000. PMID: 11063837 Clinical Trial.

5

Immunotherapy of multiple sclerosis: where are we? Where should we go?

Martin R, Stürzebecher CS, McFarland HF. Martin R, et al. Among authors: mcfarland hf. Nat Immunol. 2001 Sep;2(9):785-8. doi: 10.1038/ni0901-785. Nat Immunol. 2001. PMID: 11526386 No abstract available.

6

CD4+CD28- costimulation-independent T cells in multiple sclerosis.

Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. Markovic-Plese S, et al. Among authors: mcfarland hf. J Clin Invest. 2001 Oct;108(8):1185-94. doi: 10.1172/JCI12516. J Clin Invest. 2001. PMID: 11602626 Free PMC article.

7

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

Stürzebecher S, Wandinger KP, Rosenwald A, Sathyamoorthy M, Tzou A, Mattar P, Frank JA, Staudt L, Martin R, McFarland HF. Stürzebecher S, et al. Among authors: mcfarland hf. Brain. 2003 Jun;126(Pt 6):1419-29. doi: 10.1093/brain/awg147. Brain. 2003. PMID: 12764062

8

Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b.

Markovic-Plese S, Bielekova B, Kadom N, Leist TP, Martin R, Frank JA, McFarland HF. Markovic-Plese S, et al. Among authors: mcfarland hf. Neurology. 2003 Jun 10;60(11):1849-51. doi: 10.1212/01.wnl.0000071218.34009.af. Neurology. 2003. PMID: 12796549 Clinical Trial.

9

MRI as a marker for disease heterogeneity in multiple sclerosis.

Bielekova B, Kadom N, Fisher E, Jeffries N, Ohayon J, Richert N, Howard T, Bash CN, Frank JA, Stone L, Martin R, Cutter G, McFarland HF. Bielekova B, et al. Among authors: mcfarland hf. Neurology. 2005 Oct 11;65(7):1071-6. doi: 10.1212/01.wnl.0000178984.30534.f9. Neurology. 2005. PMID: 16217061

10

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, Patronas N, Maloni H, McFarlin DE. McFarland HF, et al. Ann Neurol. 1992 Dec;32(6):758-66. doi: 10.1002/ana.410320609. Ann Neurol. 1992. PMID: 1471866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters